BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 28476509)

  • 1. Three-Case Report of Embolic Stroke of Undetermined Source.
    Li J; Yang XZ; Wang YP; Chen XL; Zhang X
    J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):e133-e137. PubMed ID: 28476509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of Finding Embolic Sources for Patients with Embolic Stroke of Undetermined Source.
    Umemura T; Nishizawa S; Nakano Y; Saito T; Kitagawa T; Miyaoka R; Suzuki K; Yamamoto J
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1810-1815. PubMed ID: 31097326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of recurrent embolic stroke of undetermined source in a chronic kidney disease patient undergoing hemodialysis.
    Shindo M; Kaneko S; Minato S; Mutsuyoshi Y; Yanai K; Ishii H; Kitano T; Miyazawa H; Ito K; Ueda Y; Hirai K; Hoshino T; Ookawara S; Morishita Y
    Saudi J Kidney Dis Transpl; 2018; 29(5):1245-1246. PubMed ID: 30381530
    [No Abstract]   [Full Text] [Related]  

  • 4. Branch atheromatous disease diagnosed as embolic stroke of undetermined source: A sub-analysis of NAVIGATE ESUS.
    Uchiyama S; Toyoda K; Kitagawa K; Okada Y; Ameriso S; Mundl H; Berkowitz S; Yamada T; Liu YY; Hart RG;
    Int J Stroke; 2019 Dec; 14(9):915-922. PubMed ID: 31132967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical assessment of the current pharmacotherapy for the treatment of embolic strokes of undetermined source.
    Lattanzi S; Acampa M; Norata D; Broggi S; Caso V
    Expert Opin Pharmacother; 2022 Jun; 23(8):905-915. PubMed ID: 35470761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embolic Pattern of Stroke Associated with Cardiac Wall Motion Abnormalities; Narrowing the Embolic Stroke of Undetermined Source Category.
    Kamran S; Akhtar N; George P; Singh R; Imam Y; Salam A; Babu B; Burke P; Own A; Vattoth S; Perkins J; Parray A; Qadri S; Hamid T
    J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104509. PubMed ID: 31759913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial.
    Kasner SE; Lavados P; Sharma M; Wang Y; Wang Y; Dávalos A; Shamalov N; Cunha L; Lindgren A; Mikulik R; Arauz A; Lang W; Czlonkowska A; Eckstein J; Gagliardi R; Amarenco P; Ameriso SF; Tatlisumak T; Veltkamp R; Hankey GJ; Toni DS; Bereczki D; Uchiyama S; Ntaios G; Yoon BW; Brouns R; DeVries Basson MM; Endres M; Muir K; Bornstein N; Ozturk S; O'Donnell M; Mundl H; Pater C; Weitz J; Peacock WF; Swaminathan B; Kirsch B; Berkowitz SD; Peters G; Pare G; Themeles E; Shoamanesh A; Connolly SJ; Hart RG;
    J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1673-1682. PubMed ID: 29525076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embolic Stroke of Undetermined Source: A Systematic Review and Clinical Update.
    Hart RG; Catanese L; Perera KS; Ntaios G; Connolly SJ
    Stroke; 2017 Apr; 48(4):867-872. PubMed ID: 28265016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of Randomized, double-blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with Embolic Stroke of Undetermined Source (RE-SPECT ESUS).
    Diener HC; Easton JD; Granger CB; Cronin L; Duffy C; Cotton D; Brueckmann M; Sacco RL;
    Int J Stroke; 2015 Dec; 10(8):1309-12. PubMed ID: 26420134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial: Recurrent stroke risk and response to antithrombotic therapy.
    Ameriso SF; Amarenco P; Pearce LA; Perera KS; Ntaios G; Lang W; Bereczki D; Uchiyama S; Kasner SE; Yoon BW; Lavados P; Firstenfeld A; Mikulik R; Povedano GP; Ferrari J; Mundl H; Berkowitz SD; Connolly SJ; Hart RG
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104936. PubMed ID: 32689594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary Stroke Prevention in Cryptogenic Stroke and Embolic Stroke of Undetermined Source (ESUS).
    Diener HC; Bernstein R; Hart R
    Curr Neurol Neurosci Rep; 2017 Sep; 17(9):64. PubMed ID: 28707135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ticagrelor Versus Aspirin in Acute Embolic Stroke of Undetermined Source.
    Amarenco P; Albers GW; Denison H; Easton JD; Evans SR; Held P; Hill MD; Jonasson J; Kasner SE; Ladenvall P; Minematsu K; Molina CA; Wang Y; Wong KSL; Johnston SC;
    Stroke; 2017 Sep; 48(9):2480-2487. PubMed ID: 28720658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial.
    Hart RG; Veltkamp RC; Sheridan P; Sharma M; Kasner SE; Bangdiwala SI; Ntaios G; Shoamanesh A; Ameriso SF; Toni D; Czlonkowska A; Lindgren A; Hankey GJ; Perera KS; Shuaib A; Coutts SB; Gagliardi RJ; Berkowitz SD; Mundl H; Peters G; Connolly SJ;
    J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2273-2279. PubMed ID: 31160218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embolic Stroke of Undetermined Source: Gateway to a New Stroke Entity?
    Schäbitz WR; Köhrmann M; Schellinger PD; Minnerup J; Fisher M
    Am J Med; 2020 Jul; 133(7):795-801. PubMed ID: 32247819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Embolic infarct topology differs between atrial fibrillation subtypes and embolic stroke of undetermined source.
    Wolfe J; Oak S; Tiongson J; Vigilante N; Frost E; Penckofer M; Thau L; Iezzi Z; Patel P; Siegler JE
    J Stroke Cerebrovasc Dis; 2022 Nov; 31(11):106782. PubMed ID: 36130470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of recurrent ischemic stroke in young cryptogenic patients with embolic stroke of undetermined source.
    Šaňák D; Divišová P; Hutyra M; Král M; Bártková A; Zapletalová J; Látal J; Dorňák T; Hudec Š; Franc D; Polidar P; Veverka T; Kaňovský P
    J Neurol Sci; 2020 Sep; 416():116985. PubMed ID: 32563078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review and update of the concept of embolic stroke of undetermined source.
    Diener HC; Easton JD; Hart RG; Kasner S; Kamel H; Ntaios G
    Nat Rev Neurol; 2022 Aug; 18(8):455-465. PubMed ID: 35538232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embolic strokes of undetermined source in the Athens stroke registry: a descriptive analysis.
    Ntaios G; Papavasileiou V; Milionis H; Makaritsis K; Manios E; Spengos K; Michel P; Vemmos K
    Stroke; 2015 Jan; 46(1):176-81. PubMed ID: 25378429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Embolic Stroke of Undetermined Source].
    Hirano T
    Brain Nerve; 2017 Jun; 69(6):651-656. PubMed ID: 28596467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apixaban for treatment of embolic stroke of undetermined source (ATTICUS randomized trial): Rationale and study design.
    Geisler T; Poli S; Meisner C; Schreieck J; Zuern CS; Nägele T; Brachmann J; Jung W; Gahn G; Schmid E; Bäezner H; Keller T; Petzold GC; Schrickel JW; Liman J; Wachter R; Schön F; Schabet M; Lindner A; Ludolph AC; Kimmig H; Jander S; Schlegel U; Gawaz M; Ziemann U
    Int J Stroke; 2017 Dec; 12(9):985-990. PubMed ID: 27881833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.